As global pharmaceutical supply chains face cost inflation,geopolitical instability, and new frameworks such as the EU’sCritical Medicines Act, the industry is redefining what resilience means. Today, we speak with Dr. Max Lauwiner about how quality, supply chain security, and agility can coexist-notas trade-offs, but as mutually reinforcing pillars of a modern pharma ecosystem.
In the first article of this series, we explored the foundations of imide chemistry, the unique stability of the imide ring, the influence of pendant groups, and the ways these structures support advanced materials.
In this second installment, we shift from fundamentals to functional innovation and examine how tailoringimide derivatives translates into measurable performance gains.
Imides are more than functional groups – they are platforms for property tuning in high-performance materials.
In this part 1 we explore structure, key properties and where imide chemistry enables performance in polymers, resins, electronics and advanced materials.
In this episode of Pharma Matters, Dr. Luca Allievi from Valsynthese SA shares how the application of Design of Experiments (DoE) can optimize a complex chemical process — improving yield, quality, and sustainability all at once.
Dr. Luca Mantilli, R&D chemist at Valsynthese, discusses how hydrogenation was implemented to bridge the gap between two of the company’s core hazardous chemistries: nitration and phosgenation.
